{"id":"https://openalex.org/W7225617847","doi":"https://doi.org/10.3389/fonc.2026.1833590","title":"Case report: Definitive therapy for local progression in patients with responding metastatic HER2-positive breast cancer","display_name":"Case report: Definitive therapy for local progression in patients with responding metastatic HER2-positive breast cancer","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225617847","doi":"https://doi.org/10.3389/fonc.2026.1833590"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1833590","doi":"https://doi.org/10.3389/fonc.2026.1833590","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1833590","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1833590/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1833590/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062446308","display_name":"Yael Berner-Wygoda","orcid":"https://orcid.org/0000-0001-8291-5578","observed_orcids":["https://orcid.org/0000-0001-8291-5578"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA","IL"],"is_corresponding":true,"raw_author_name":"Yael Berner-Wygoda","raw_affiliation_strings":["Breast Cancer Unit, Sharett Institute of Oncology, Hadassah University Hospital","Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Cancer Unit, Sharett Institute of Oncology, Hadassah University Hospital","institution_ids":["https://openalex.org/I2799899409"]},{"raw_affiliation_string":"Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040335322","display_name":"Meredith Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297363086","display_name":"St. Michael's Hospital","ror":"https://ror.org/04skqfp25","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]},{"id":"https://openalex.org/I4399598460","display_name":"Unity Health Toronto","ror":"https://ror.org/012x5xb44","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4399598460"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Meredith Li","raw_affiliation_strings":["Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto","Unity Health Toronto, Division of Medical Oncology & Hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2802654988"]},{"raw_affiliation_string":"Unity Health Toronto, Division of Medical Oncology & Hematology","institution_ids":["https://openalex.org/I1297363086","https://openalex.org/I4399598460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5135053864","display_name":"Mitchell Elliott","orcid":"https://orcid.org/0000-0001-6711-7287","observed_orcids":["https://orcid.org/0000-0001-6711-7287"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mitchell Elliott","raw_affiliation_strings":["Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088092036","display_name":"Jacqueline Savill","orcid":"https://orcid.org/0009-0000-9751-9391","observed_orcids":["https://orcid.org/0009-0000-9751-9391"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jacqueline Savill","raw_affiliation_strings":["Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034396461","display_name":"Neha Pathak","orcid":"https://orcid.org/0000-0002-1077-5358","observed_orcids":["https://orcid.org/0000-0002-1077-5358"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Neha Pathak","raw_affiliation_strings":["Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089936849","display_name":"Michelle B. Nadler","orcid":"https://orcid.org/0000-0002-4372-3204","observed_orcids":["https://orcid.org/0000-0002-4372-3204"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Michelle B. Nadler","raw_affiliation_strings":["Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161324319","display_name":"Vikaash Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Vikaash Kumar","raw_affiliation_strings":["Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138682735","display_name":"Philippe L. Bedard","orcid":"https://orcid.org/0000-0002-6771-2999","observed_orcids":["https://orcid.org/0000-0002-6771-2999"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Philippe L. Bedard","raw_affiliation_strings":["Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060911347","display_name":"David W. Cescon","orcid":"https://orcid.org/0000-0002-1080-0998","observed_orcids":["https://orcid.org/0000-0002-1080-0998"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"David W. Cescon","raw_affiliation_strings":["Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2802654988"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102844847","display_name":"Eitan Amir","orcid":"https://orcid.org/0000-0002-3706-525X","observed_orcids":["https://orcid.org/0000-0002-3706-525X"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Eitan Amir","raw_affiliation_strings":["Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2802654988"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5062446308"],"corresponding_institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2799899409","https://openalex.org/I2802654988"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.82669997215271,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.82669997215271,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.13899999856948853,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9829999804496765},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.949999988079071},{"id":"https://openalex.org/keywords/local-progression","display_name":"local progression","score":0.7580000162124634},{"id":"https://openalex.org/keywords/locoregional-progression","display_name":"locoregional progression","score":0.984000027179718},{"id":"https://openalex.org/keywords/isolated-local-recurrence","display_name":"isolated local recurrence","score":0.5820000171661377},{"id":"https://openalex.org/keywords/mastectomy","display_name":"mastectomy","score":0.8740000128746033},{"id":"https://openalex.org/keywords/breast-conserving-surgery","display_name":"breast-conserving surgery","score":0.9980000257492065},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.8420000076293945},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8669999837875366},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":1.0},{"id":"https://openalex.org/keywords/taxane-based-chemotherapy","display_name":"taxane-based chemotherapy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.7369999885559082},{"id":"https://openalex.org/keywords/ductal-carcinoma-in-situ","display_name":"ductal carcinoma in situ","score":0.5830000042915344},{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9617000222206116},{"id":"https://openalex.org/C2779572924","wikidata":"https://www.wikidata.org/wiki/Q542022","display_name":"Lumpectomy","level":5,"score":0.7631000280380249},{"id":"https://openalex.org/C185926286","wikidata":"https://www.wikidata.org/wiki/Q1929812","display_name":"Systemic therapy","level":4,"score":0.6477000117301941},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5861999988555908},{"id":"https://openalex.org/C2777757722","wikidata":"https://www.wikidata.org/wiki/Q848318","display_name":"Mastectomy","level":4,"score":0.5805000066757202},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.5767999887466431},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5550000071525574},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5259000062942505},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4964999854564667},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4903999865055084},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4708000123500824},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4490000009536743},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.44269999861717224},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.4318999946117401},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38339999318122864},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.36579999327659607},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.35109999775886536},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3400999903678894},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.33399999141693115},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.33059999346733093},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.33000001311302185},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.3296999931335449},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3111000061035156},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.310699999332428},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.2992999851703644},{"id":"https://openalex.org/C2778674544","wikidata":"https://www.wikidata.org/wiki/Q1414805","display_name":"Systemic disease","level":3,"score":0.2797999978065491},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.2727000117301941}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fonc.2026.1833590","doi":"https://doi.org/10.3389/fonc.2026.1833590","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1833590","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1833590/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1833590","doi":"https://doi.org/10.3389/fonc.2026.1833590","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1833590","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1833590/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225617847.pdf","grobid_xml":"https://content.openalex.org/works/W7225617847.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W2102032555","https://openalex.org/W2137228442","https://openalex.org/W2804086994","https://openalex.org/W4205202585","https://openalex.org/W4281761766","https://openalex.org/W4389752877","https://openalex.org/W4401689284","https://openalex.org/W4407438715","https://openalex.org/W4409654340","https://openalex.org/W4415677336","https://openalex.org/W4417207628","https://openalex.org/W7125981927","https://openalex.org/W7170093658"],"related_works":["https://openalex.org/W7129538678","https://openalex.org/W4417207628","https://openalex.org/W2531899626","https://openalex.org/W7169715903","https://openalex.org/W2204497908","https://openalex.org/W1977009893","https://openalex.org/W7129446106","https://openalex.org/W2481553405","https://openalex.org/W4319057690","https://openalex.org/W2220955451"],"abstract_inverted_index":{"Background":[0],"The":[1],"role":[2,269],"of":[3,7,31,61,91,103,107,201,236,259,270],"definitive":[4,86],"locoregional":[5,82,156],"treatment":[6,97,113,160,197,242],"the":[8,29,38,220,237,268],"primary":[9,39],"tumor":[10,40],"in":[11,42,163,168,245,273],"de":[12],"novo":[13],"metastatic":[14,47],"breast":[15],"cancer":[16],"(MBC)":[17],"remains":[18],"controversial,":[19],"with":[20,44,63,114,140],"randomized":[21],"trials":[22],"largely":[23],"demonstrating":[24],"no":[25],"survival":[26],"benefit.":[27],"In":[28],"era":[30],"effective":[32],"HER2-targeted":[33,92,196],"therapies,":[34],"isolated":[35,78],"progression":[36,83,153],"at":[37,67,129,187,210],"site":[41],"patients":[43,62,122,132,150,165,171,192],"otherwise":[45],"well-controlled":[46],"disease":[48],"represents":[49],"an":[50],"emerging":[51],"clinical":[52,79],"scenario.":[53],"Methods":[54],"We":[55],"conducted":[56],"a":[57,199,256],"retrospective":[58],"case":[59,248],"series":[60],"HER2-positive":[64],"MBC":[65],"treated":[66],"our":[68],"institution":[69],"between":[70],"January":[71,118],"2007":[72],"and":[73,84,96,154,166],"June":[74],"2025":[75],"who":[76,226],"developed":[77],"local":[80,87,112,152,159,190,241,260],"or":[81,141],"underwent":[85],"therapy":[88,110],"without":[89,142],"modification":[90],"systemic":[93,109,222],"therapy.":[94],"Patient":[95],"characteristics":[98],"were":[99,123],"summarized":[100],"descriptively.":[101],"Outcomes":[102],"interest":[104],"included":[105,161],"duration":[106],"continued":[108,193],"following":[111],"follow":[115,212],"up":[116],"until":[117],"2026.":[119],"Results":[120],"Nine":[121],"identified.":[124],"Seven":[125],"had":[126],"liver":[127],"metastases":[128],"diagnosis.":[130],"All":[131],"received":[133,172],"taxane-based":[134],"chemotherapy":[135],"followed":[136],"by":[137],"maintenance":[138,195],"trastuzumab":[139],"pertuzumab;":[143],"seven":[144,164],"achieved":[145],"complete":[146],"radiologic":[147],"response.":[148],"Six":[149],"experienced":[151],"three":[155],"progression.":[157,188,232],"Definitive":[158],"mastectomy":[162],"lumpectomy":[167],"two.":[169],"Three":[170],"radiotherapy.":[173],"One":[174],"surgical":[175],"specimen":[176],"contained":[177],"DCIS":[178],"only;":[179],"all":[180,217],"other":[181],"invasive":[182],"tumors":[183],"retained":[184],"HER2":[185],"positivity":[186],"Following":[189],"therapy,":[191],"first-line":[194],"for":[198],"median":[200],"45":[202],"months":[203],"(range":[204],"11-156),":[205],"including":[206],"eight":[207],"ongoing":[208],"observations":[209,252],"last":[211,215],"up.":[213],"At":[214],"follow-up,":[216],"remained":[218],"on":[219],"same":[221],"regimen":[223],"except":[224],"one":[225],"transitioned":[227],"to":[228,266],"TDxd":[229],"after":[230,240],"intracranial":[231],"Conclusion":[233],"Continued":[234],"use":[235],"anti-HER2":[238],"backbone":[239],"was":[243],"observed":[244],"this":[246,271],"selected":[247,275],"series.":[249],"Although":[250],"these":[251],"do":[253],"not":[254],"establish":[255],"causal":[257],"benefit":[258],"intervention,":[261],"they":[262],"support":[263],"further":[264],"studies":[265],"define":[267],"approach":[272],"appropriately":[274],"patients.":[276]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}